Harnessing the power of novel animal-free test methods for the development of COVID-19 drugs and vaccines Aug 1, 2022 | 2020, Archives of Toxicology, Publication - legacy work ‹ Previous Internationalization of read-across as a validated new approach method (NAM) for regulatory toxicology Next › The EU-ToxRisk method documentation, data processing and chemical testing pipeline for the regulatory use of new approach methods
